Atraverse Medical Announces First Clinical Use of HOTWIRE™ Radiofrequency (RF) Guidewire System at St. Bernards Medical Center

Atraverse Medical HOTWIRE™ RF guidewire device has been used for the first time in clinical practice by world-renowned cardiac electrophysiologist, Dr. Devi Nair, at St. Bernards Medical Center. The best-in-class left-heart access device received FDA 510(k) clearance earlier this year and was unveiled at the Heart Rhythm Society congress in May.

Co-founded by Dr. Steven Mickelsen, the pioneer of Farapulse pulsed field ablation technology, Atraverse’s HOTWIRE™ device is a novel radiofrequency (RF) guidewire that enables zero exchange left-heart access while acting as a rail for catheter-based therapy systems. Featuring universal sheath compatibility, the HOTWIRE™ is designed to improve patient outcomes and streamline procedural workflows.

“We are thrilled to use the HOTWIRE™ in our clinical practice and are proud to be first in the world to utilize this innovative technology,” commented Dr. Nair, who performed twelve cases after crossing the septum with the HOTWIRE™, including four atrial fibrillation ablation procedures and eight left atrial appendage closures, while utilizing five different models of transseptal sheaths. “We have been eagerly awaiting a sheath-agnostic solution like this, and we look forward to using the product in a majority of our cases going forward for left atrial access.”

Eric Sauter, COO and Co-Founder for Atraverse Medical, commented…

“Our mission is to improve efficiency and take the guesswork out of what should be simply-executed therapeutic and diagnostic procedures. Our collaboration with Dr. Nair exemplifies our dedication to taking patient care to the next level with innovative technologies.”

In addition, the company has strengthened its executive leadership team with two industry veterans in support of its commercialization plan. Jay Kelley, MBA, who joined the Atraverse Medical team as Vice President of Marketing in 2023, has been promoted to Chief Marketing Officer.  Mr. Kelley has been instrumental in the development of Atraverse’s commercialization strategy to drive market adoption with a focused launch. He has more than 20 years of medical device R&D and commercialization experience, primarily focused on cardiac electrophysiology.

Most recently, in May of 2024, Brandon Allen joined Atraverse as Vice President of Sales.  Mr. Allen brings two decades of experience in the cardiac electrophysiology space, serving with market leaders including Biosense and Guidant / Boston Scientific, and has propelled the company forward following the FDA 510(k) clearance of the HOTWIRE™.

“Our HOTWIRE™ device has gained the attention of several thought leaders in the field, and we are excited to have Jay and Brandon on the team leading commercialization efforts,” noted John Slump, CEO and Co-Founder of Atraverse Medical. “Their deep experience and impeccable reputations are a tremendous asset to our company.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.